MedPath

KLSMC Stem Cells, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee

Phase 2
Completed
Conditions
Articular Cartilage Disorder of Knee
Articular Cartilage; Degeneration
First Posted Date
2017-04-04
Last Posted Date
2022-08-16
Lead Sponsor
KLSMC Stem Cells, Inc.
Target Recruit Count
120
Registration Number
NCT03101163
Locations
🇺🇸

Andrews Research & Education Foundation (AREF), Gulf Breeze, Florida, United States

🇲🇾

Kuala Lumpur Sports Medicine Centre, Kuala Lumpur, Malaysia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.